CHM 0.00% 1.4¢ chimeric therapeutics limited

Here is a slide from a cellular immunotherapy presentation that...

  1. 79 Posts.
    lightbulb Created with Sketch. 32
    Here is a slide from a cellular immunotherapy presentation that highlights just how novel the CDH17 antigen target is….admittedly it’s a few years old but clearly shows that CDH17 is a relatively new target. This effectively means other companies are at least 10 years behind CHM in clinical development process….

    https://hotcopper.com.au/data/attachments/6324/6324897-237b21701d3c6d3beb1e2a6876b9195f.jpg
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.